|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02186 LUYE PHARMA
Nominal 
2.830 +0.040 (+1.434%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Turnover | 3,074,582 | 5.870% | 2,904,108 | 2,850,826 | 2,951,664 | 2,962,201 |
| Cost of Sales | (996,032) | 3.673% | (960,745) | (800,742) | (997,983) | (764,336) |
| Gross Profit | 2,078,550 | 6.956% | 1,943,363 | 2,050,084 | 1,953,681 | 2,197,865 |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 345 | 48.707% | 232 | 568 | 358 | 1,026 | |
| Profit / (Loss) before Taxation | 529,977 | 131.443% | 228,988 | 375,373 | 488,436 | 684,575 | |
| Taxation | (91,799) | 9.763% | (83,634) | (72,187) | (80,446) | (144,247) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (50,342) | -- | 4,623 | (6,189) | (21,405) | (912) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 387,836 | 158.597% | 149,977 | 296,997 | 386,585 | 539,416 | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 234,134 | -8.386% | 255,565 | 168,666 | 140,890 | 178,124 |
| Depreciation & Amortisation | 348,305 | 5.091% | 331,431 | 326,472 | 270,260 | 254,687 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| EPS (cts) | 10.310 | 153.941% | 4.060 | 8.540 | 11.320 | 16.900 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 3.461 | -- | 3.013 | 2.403 | 2.498 | 2.360 |
| Remarks: | Real time quote last updated: 01/11/2024 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 387,836 |
| %Change | 158.597% |
| EPS / (LPS) | RMB 0.103 |
| NBV Per Share (¥) | RMB 3.461 |